Shengsen Chen
Impact in
-
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Gastric Cancer Management and Outcomes 8
- Lung Cancer Diagnosis and Treatment 2
- Surgery 6
- Esophageal Cancer Research and Treatment 4
- Co-authors
- Kangkang Yu (7 shared papers)Chong Huang (8 shared papers)Mengqi Zhu (7 shared papers)Qi Cheng (6 shared papers)Mingquan Chen (8 shared papers)Choon Nam Ong (4 shared papers)Yonghai Lu (4 shared papers)Liang Gao (2 shared papers)
- Journals
- Frontiers in Medicine (3 papers)Frontiers in Oncology (2 papers)Metabolomics (2 papers)Scientific Reports (2 papers)Digestive and Liver Disease (1 paper)
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Shengsen Chen
22 papers receiving 319 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 70
- Hepatology 21
- Biochemistry 19
- Molecular Biology 148
- Epidemiology 59
Countries citing papers authored by Shengsen Chen
This map shows the geographic impact of Shengsen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengsen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengsen Chen more than expected).
Fields of papers citing papers by Shengsen Chen
This network shows the impact of papers produced by Shengsen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengsen Chen. The network helps show where Shengsen Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Shengsen Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 87 | |
| 2 | 2017 | 41 | |
| 3 | Epigenetic silencing of dual oxidase 1 by promoter hypermethylation in human hepatocellular carcinoma. | 2014 | 39 |
| 4 | 2015 | 27 | |
| 5 | 2016 | 17 | |
| 6 | 2022 | 14 | |
| 7 | 2017 | 13 | |
| 8 | 2017 | 12 | |
| 9 | 2021 | 11 | |
| 10 | 2021 | 10 | |
| 11 | 2018 | 10 | |
| 12 | 2022 | 7 | |
| 13 | 2023 | 6 | |
| 14 | 2024 | 5 | |
| 15 | 2016 | 5 | |
| 16 | 2022 | 4 | |
| 17 | 2021 | 4 | |
| 18 | 2021 | 4 | |
| 19 | 2023 | 3 | |
| 20 | 2023 | 3 |
About Shengsen Chen
Shengsen Chen is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, Epidemiology and Cancer Research, having authored 24 papers that have together received 324 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (8 papers), Esophageal Cancer Research and Treatment (4 papers), Liver Disease Diagnosis and Treatment (3 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Bacterial Infections and Vaccines (2 papers), Influenza Virus Research Studies (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Cancer Research (70 citations), Hepatology (21 citations), Biochemistry (19 citations), Molecular Biology (148 citations) and Epidemiology (59 citations). Shengsen Chen has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Kangkang Yu, Chong Huang, Mengqi Zhu, Qi Cheng, Mingquan Chen, Choon Nam Ong, Yonghai Lu, Liang Gao, Yong‐Jiang Xu and Shi Wang. Their work appears in journals such as Frontiers in Medicine, Frontiers in Oncology, Metabolomics, Scientific Reports and Digestive and Liver Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.